TY - JOUR T1 - Molecular Imaging of Cardiac Amyloidosis JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 965 LP - 970 DO - 10.2967/jnumed.120.245381 VL - 61 IS - 7 AU - Ahmad Masri AU - Syed Bukhari AU - Yvonne S. Eisele AU - Prem Soman Y1 - 2020/07/01 UR - http://jnm.snmjournals.org/content/61/7/965.abstract N2 - Transthyretin and light-chain amyloidosis are the 2 main causes of cardiac amyloidosis. Recent developments in molecular imaging have transformed our ability to diagnose transthyretin cardiac amyloidosis noninvasively and unmasked a hitherto unrecognized prevalence of the disease. This review summarizes the current and evolving imaging approaches, their molecular structural basis, and the gaps in imaging capabilities that have arisen as a result of parallel developments in pharmacotherapy delivering the first effective treatment options for this condition. ER -